Status:
COMPLETED
Supporting Cognitive Control Training With tDCS
Lead Sponsor:
University Hospital Tuebingen
Conditions:
Cognitive Control
Eligibility:
All Genders
18-40 years
Phase:
NA
Brief Summary
Cognitive control (CC) is an important prerequisite for goal-directed behaviour and often associated with dysfunctional prefrontal activity within the cortex. This can be ameliorated by non-invasive b...
Eligibility Criteria
Inclusion
- Healthy subjects
- Right-handed (assessed by Edinburgh Handedness Inventory)
- No other concurrent brain stimulation during participation
- Proficient in German (min. CEFR level B)
- Ability to strictly adhere to study timeline
Exclusion
- Diagnosed neurological illnesses
- Diagnosed psychiatric disorders
- Achromatopsia
- Metallic implants / tattoos on or near electrode sites
- Consumption of tobacco to an equivalent of ten or more cigarettes per day
- Prior participation in experiments involving the PASAT
Key Trial Info
Start Date :
April 15 2016
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 26 2018
Estimated Enrollment :
173 Patients enrolled
Trial Details
Trial ID
NCT04108663
Start Date
April 15 2016
End Date
March 26 2018
Last Update
September 30 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Tübingen, Department of Psychiatry and Psychotherapy
Tübingen, Germany, 72074